Recently, Ponath et al. demonstrated that the MS risk variant rs7665090G, which is located near NFKB1, is associated with upregulated NF-κB and target gene expression (e.g., IFN-γ and TNF-α) in human astrocytes (30). The gene discussed is NFKB1; the disease is myeloid sarcoma.